Fresenius Kabi Pharmaceuticals (APCVZ)

[zeus_0100]

shortages at app,
so many need this and short supply,

Products Affected - Description
Thiamine hydrochloride (vitamin B1) for injection 100 mg/mL, 1 mL vials (NDC 63323-0013-02), APP

Reason for the Shortage

APP could not provide a reason for the shortage. APP is the sole supplier of thiamine injection.
Oral preparations of thiamine are not affected by this shortage.

Estimated Resupply Dates
APP has thiamine injection on back order and the company estimates a release date of late-August, 2010.

Tobramycin Solution for Injection, APP
40 mg/mL, 50 mL vial (NDC 63323-0306-51)
40 mg/mL, 2 mL Novaplus vial (NDC 63323-0306-55)

Estimated Resupply Dates

APP has available tobramycin 40 mg/mL solution for injection in 2 mL (NDC 63323-0306-02), 30 mL (NDC 63323-0306-30), and 30 mL Novaplus (NDC 63323-0306-56) vials. Tobramycin 50 mL vials and 2 mL Novaplus vials are on back order with an estimated release date of late-August, 2010